Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Receivables: 2020-2024

Historic Receivables for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $10.2 million.

  • Journey Medical's Receivables rose 68.52% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.9 million, marking a year-over-year increase of 34.07%. This contributed to the annual value of $10.2 million for FY2024, which is 32.79% down from last year.
  • Latest data reveals that Journey Medical reported Receivables of $10.2 million as of FY2024, which was down 32.79% from $15.2 million recorded in FY2023.
  • Over the past 5 years, Journey Medical's Receivables peaked at $28.2 million during FY2022, and registered a low of $10.2 million during FY2024.
  • Over the past 3 years, Journey Medical's median Receivables value was $15.2 million (recorded in 2023), while the average stood at $17.9 million.
  • As far as peak fluctuations go, Journey Medical's Receivables increased by 22.05% in 2022, and later crashed by 46.04% in 2023.
  • Over the past 5 years, Journey Medical's Receivables (Yearly) stood at $23.9 million in 2020, then declined by 3.41% to $23.1 million in 2021, then climbed by 22.05% to $28.2 million in 2022, then plummeted by 46.04% to $15.2 million in 2023, then crashed by 32.79% to $10.2 million in 2024.